11th Pharmacovigilance 2016

Країна: Індія

Місто: Mumbai

Тези до: 24.11.2016

Дати: 01.12.16 — 01.12.16

Е-мейл Оргкомітету: info@virtueinsight.com

Організатори: Virtue Insight

 

After the successful journey of a series of 10 Pharmacovigilance conferences, Virtue Insight is proud to announce its 11th Pharmacovigilance 2016 in India.

It is our great pleasure to invite you to the 11th Pharmacovigilance 2016, in Mumbai - India on 1st of December 2016. We have a wide range of scientific topics with something for everyone.

The past is reflected in a session about Indian traditional medicine and the future is discussed under Big Data analytics and in the research of our young scientists. However, we must live and act in the present and debate pressing challenges that face us today in pharmacovigilance (PV). The rates for medication errors are too high. We still struggle to communicate risk well. With the welcome drive towards transparency and respecting human rights, legal and ethical issues in PV have come to the fore. Society’s research enterprise as a whole needs to become far more aware of the commercial reality that PV underpins safety, with its intimate links to innovation, so that safety and must be intrinsically built into successful development and marketing. With governments round the world struggling to curb healthcare costs, the importance of integrating PV into National Health Programmes has never been more important.

It gives me great pleasure in welcoming all of you to the virtue insight’s 11th Pharmacovigilance 2016. I wish and pray that all our efforts will be beneficial to our industries and to our country at large.

 

KEY THEMES DISCUSSED AT THIS CONFERENCE:-

    Updates - legislation, policies, systems, technology, communication strategies and best practice in PV
    Lessons to learn - Pharmacovigilance Programme of India (PvPI)
    Clinical Trial Safety: Shift from Explanatory to Pragmatic Trials
    Developing pharmacovigilance into high quality management system and its components
    Integrate digital health initiative to minimize risks and enhance patient safety
    Indigenous medicines for sex selection during pregnancy: How safe is it?
    Negotiating Country-Specific annexes and adapting Risk Management Plans (RMPs) to Asia
    Developing a refinement of quality in people, process and technology within your PV system
    Changing landscape of PV technologies
    Assuring certain submission in Patient Support Programs (PSP): Leveraging organizational collaboration to enhance data capture
    Understanding the Indian Medical Association (IMA) good practice guide on risk minimization and prevention of medication errors
    Mobile Apps to enforce pharmacovigilance and risk minimisation interventions
    Using big data to advance drug safety
    Negotiating the regulatory environment
    Accelerating new medicine introduction in developing world & overcoming challenges
    Be part of a major networking opportunity

Веб-сторінка конференції: http://www.virtueinsight.com/pharma/11th-Pharmacovigilance-2016/